Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alnylam Pharmaceuticals
(NQ:
ALNY
)
234.29
-1.30 (-0.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
745,979
Open
236.12
Bid (Size)
230.00 (1)
Ask (Size)
240.25 (10)
Prev. Close
235.59
Today's Range
231.01 - 238.53
52wk Range
141.97 - 263.73
Shares Outstanding
118,847,693
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
July 22, 2024
Ionis Pharmaceuticals releases positive results from Phase 1/2 study of ION582 for Angelman syndrome, showing consistent clinical improvements in communication, cognition, and motor function. Safety...
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $4,100 Today
July 18, 2024
Via
Benzinga
Performance
YTD
+20.19%
+20.19%
1 Month
+5.11%
+5.11%
3 Month
+60.40%
+60.40%
6 Month
+23.51%
+23.51%
1 Year
+21.82%
+21.82%
More News
Read More
Alnylam to Webcast Conference Call Discussing Second Quarter 2024 Financial Results
July 18, 2024
From
Alnylam Pharmaceuticals, Inc.
Via
Business Wire
Alnylam Stock Is a Blockbuster Biopharma In the Making
July 18, 2024
Via
InvestorPlace
Peering Into Alnylam Pharmaceuticals's Recent Short Interest
July 17, 2024
Via
Benzinga
Peering Into Alnylam Pharmaceuticals's Recent Short Interest
June 27, 2024
Via
Benzinga
35% Surge Just the Beginning? Alnylam’s Stock Poised for Massive Gains on Heart Drug Success.
July 11, 2024
Via
InvestorPlace
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
Via
InvestorPlace
Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?
July 08, 2024
Via
The Motley Fool
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
Via
Benzinga
Topics
ETFs
$100 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
July 03, 2024
Via
Benzinga
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
July 01, 2024
Via
Benzinga
Topics
ETFs
10 Health Care Stocks With Whale Alerts In Today's Session
July 01, 2024
Via
Benzinga
Rivian Automotive And Carvana Were Among The 10 Biggest Large Cap Gainers Last Week (June 23-June 29): Are These In Your Portfolio?
June 30, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 26, 2024
Via
Benzinga
Nvidia, Affirm Holdings, Carnival Corp, Alnylam Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today
June 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Semiconductor, Nvidia Woes Deepen; Nasdaq 100 Slips, Dow Rallies; Bitcoin Sinks To $60,400: What's Driving Markets Monday?
June 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears
June 24, 2024
Via
InvestorPlace
Exposures
Product Safety
Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success
June 24, 2024
Via
InvestorPlace
Alnylam's Closely Watched Phase 3 Heart Disease Trial Of Vutrisiran Hits Primary Endpoint, Shares Surge
June 24, 2024
Via
Benzinga
Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug
June 24, 2024
Via
Investor's Business Daily
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 24, 2024
Via
Benzinga
Alnylam Reports Positive Topline Results from HELIOS-B Phase 3 Study of Vutrisiran, Achieving Statistical Significance on Primary and All Secondary Endpoints in Both Overall and Monotherapy Populations
June 24, 2024
From
Alnylam Pharmaceuticals, Inc.
Via
Business Wire
Masters In Trading - Saturday, June 22
June 22, 2024
Via
Talk Markets
Here's How Much $1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today
June 14, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.